Session » Abstracts: Vasculitis – Non-ANCA-Associated & Related Disorders I: Clinical Trials
- 1:00PM-2:30PM
-
Abstract Number: 1699
Anakinra in Giant Cell Arteritis: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial
- 1:00PM-2:30PM
-
Abstract Number: 1698
Assessment of the Remission Maintenance After Tocilizumab Withdrawal in Polymyalgia Rheumatica Patients Receiving a 6-month Treatment
- 1:00PM-2:30PM
-
Abstract Number: 1700
Comparative Effectiveness of Sarilumab vs. Methotrexate as a Glucocorticoid-Sparing Agent in Patients with Polymyalgia Rheumatica
- 1:00PM-2:30PM
-
Abstract Number: 1696
Comparison of Mycophenolate Mofetil Plus Methotrexate versus Cyclophosphamide with Sequential Azathioprine for Active Takayasu’s Arteritis: An Open-Label, Randomized-Controlled Trial
- 1:00PM-2:30PM
-
Abstract Number: 1695
Efficacy of Upadacitinib in Patients with Giant Cell Arteritis: Subgroup Analysis of the SELECT-GCA Phase 3 Trial